Publications by authors named "Jane Matthews"

Claim this Profile
C
Clinical outcomes and programming strategies of implantable cardioverter-defibrillator devices in paediatric hypertrophic cardiomyopathy: a UK National Cohort Study.
Gabrielle Norrish, Henry Chubb, Ella Field, Karen McLeod, Maria Ilina, Jane Matthews

Europace· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial.
Mark Hertzberg, Jane Palfrey Matthews, Janey Malka Stone, Ming-Celine Dubosq, Andrew Grigg

Am J Hematol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of smoking cessation to prevent age-related macular degeneration.
Susan F Hurley, Jane P Matthews, Robyn H Guymer

Cost Eff Resour Alloc· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration.
Susan F Hurley, Jane P Matthews, Robyn H Guymer

Cost Eff Resour Alloc· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flexible low-intensity combination chemotherapy for elderly patients with acute myeloid leukaemia: a multicentre, phase II study.
Arumugam Manoharan, John Reynolds, Jane Matthews, Heather Baxter, Juliana Di Iulio

Drugs Aging· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Quit Benefits Model: a Markov model for assessing the health benefits and health care cost savings of quitting smoking.
Susan F Hurley, Jane P Matthews

Cost Eff Resour Alloc· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement.
Janine Campbell, John F Seymour, Jane Matthews, Max Wolf, Janey Stone

Eur J Haematol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected long-term survival after low-dose palliative radiotherapy for non-small cell lung cancer.
Michael P Mac Manus, Jane P Matthews, Morikatsu Wada, Andrew Wirth, Valentina Worotniuk

Cancer· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.
Victor Kalff, Cuong Duong, Elizabeth G Drummond, Jane P Matthews, Rodney J Hicks

J Nucl Med· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure.
Michael P Mac Manus, Rodney J Hicks, Jane P Matthews, Andrew Wirth, Danny Rischin

Lung Cancer· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine.
Kenneth F Bradstock, Jane P Matthews, Raymond M Lowenthal, Heather Baxter, John Catalano

Blood· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck.
Robert E Ware, Jane P Matthews, Rodney J Hicks, Sandro Porceddu, Annette Hogg

Head Neck· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation.
Rodney J Hicks, Michael P Mac Manus, Jane P Matthews, Annette Hogg, David Binns

Int J Radiat Oncol Biol Phys· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer.
Michael P Mac Manus, Rodney J Hicks, Jane P Matthews, Allan McKenzie, Danny Rischin

J Clin Oncol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the biological activity of grade GUR 1120 and GUR 415HP UHMWPE wear debris.
Joanne Ingram, Jane Bridget Matthews, Joanne Tipper, Martin Stone, John Fisher

Biomed Mater Eng· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center.
Michael P Mac Manus, Kevin Wong, Rodney J Hicks, Jane P Matthews, Andrew Wirth

Int J Radiat Oncol Biol Phys· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis